Genzyme Sues To Stop Generic Leukemia Drug Application
Biotech company Genzyme Corp. on Wednesday filed a suit in New Jersey federal court to block Emcure Pharmaceutical Ltd.'s application for a generic version of the leukemia injection drug Clolar....To view the full article, register now.
Already a subscriber? Click here to view full article